![](https://cdn.sanity.io/images/0vv8moc6/genetherapy/22ecf2925b947d9778d05f55cfa7784714735369-300x300.png?fit=crop&auto=format)
FDA Approves Adaptimmune’s TCR T-cell Therapy Afami-cel for Synovial Sarcoma
This is a developing story and will be updated with new information as it becomes available. The FDA has granted accerlated approval to Adaptimmune Therapeutics’ afamitresgene autoleucel (afami-cel, formerly ADP-A2M4), an investigational T-cell receptor ( …